First Horizon Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.7K | Sell |
4,488
-2,405
| -35% | -$12.2K | ﹤0.01% | 1370 |
|
|
2025
Q1 | $36.5K | Sell |
6,893
-1,652
| -19% | -$8.74K | ﹤0.01% | 1073 |
|
|
2024
Q4 | $57.8K | Buy |
8,545
+487
| +6% | +$3.29K | ﹤0.01% | 889 |
|
|
2024
Q3 | $53.1K | Buy |
8,058
+1,157
| +17% | +$7.63K | ﹤0.01% | 960 |
|
|
2024
Q2 | $51.8K | Buy |
6,901
+707
| +11% | +$5.3K | ﹤0.01% | 902 |
|
|
2024
Q1 | $61.8K | Buy |
6,194
+1,429
| +30% | +$14.2K | ﹤0.01% | 855 |
|
|
2023
Q4 | $47K | Buy |
+4,765
| New | +$47K | ﹤0.01% | 968 |
|